EXL selected by HealthPartners to develop next-generation care management platformMonday, April 11, 2022
EXL CareRadius™ delivers integrated population health analytics to identify at-risk patients, spot gaps in care and drive more streamlined care management
NEW YORK, April 11, 2022 - EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, today announced that it was selected by HealthPartners, the largest consumer-governed, non-profit health care organization in the nation, to develop a next-generation care management solution. Leveraging EXL’s CareRadius™ platform, HealthPartners will now be able to incorporate powerful population health analytics directly into its care management workflow, delivering more targeted, timely and effective interventions and improved member engagement.
“In order to deliver truly patient-centric, value-based care it is essential for us to be able to build upon our capability to pull together data from multiple disparate sources, quickly analyze trends, identify gaps and develop personalized care management plans for each of our members,” said Jason Gallagher, Vice President, Health and Care Engagement at HealthPartners. “With its deep domain expertise in healthcare and insurance, and market-leading analytics and care management platform capabilities, EXL was the ideal partner to help us set the new standard for proactive care management.”
The EXL CareRadius platform is the industry’s only care management solution to integrate robust population health analytics directly into its workflow, giving health plans, providers and large employers the ability to develop personalized care management programs at scale. With seamless, bi-directional integration and electronic health record (EHR) systems, the platform supports coordinated care delivery through real-time insights across health plans, practitioners, and third-party care teams.
“Effective care management requires a real-time view of patient engagement with the healthcare system, whether that care is occurring in a primary care physician’s office, with a specialist, at a retail clinic or via telehealth,” said Sam Meckey, Executive Vice President and Business Head at EXL Health. “By integrating data from multiple external data sources into automated workflows, EXL’s CareRadius makes it possible to not only coordinate and collaborate more effectively, it also provides critical insights on gaps in care that need to be addressed. We’re thrilled to implement this groundbreaking solution with HealthPartners to help redefine effective value-based care.”
For more information about EXL’s CareRadius care management solution, please click here.
EXL (NASDAQ: EXLS) is a leading data analytics and digital operations and solutions company that partners with clients to improve business outcomes and unlock growth. By bringing together deep domain expertise with robust data, powerful analytics, cloud, artificial intelligence (“AI”) and machine learning (“ML”), we create agile, scalable solutions and execute complex operations for the world’s leading corporations in industries including insurance, healthcare, banking and financial services, media, and retail, among others. Focused on driving faster decision-making and transforming operating models, EXL was founded on the core values of innovation, collaboration, excellence, integrity and respect. Headquartered in New York, our team is over 37,400 strong, with more than 50 offices spanning six continents. For more information, visit www.exlservice.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to successfully close and integrate strategic acquisitions, our ability to respond to and manage public health crises, including the outbreak and continued effects of the coronavirus (COVID-19) pandemic, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Quarterly Report on Form 10-Q and Annual Report on Form 10-K. These risks could cause actual results to differ materially from those implied by forward-looking statements in this release. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.